XML 9 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
License And Other arrangements (Details) (USD $)
3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jul. 31, 2008
Santarus Inc. [Member]
Jun. 30, 2012
Santarus Inc. [Member]
Jun. 30, 2011
Santarus Inc. [Member]
Jun. 30, 2012
Santarus Inc. [Member]
Jun. 30, 2011
Santarus Inc. [Member]
Jun. 30, 2012
Ventiv Commercial Services, LLC [Member]
Jun. 30, 2012
Ventiv Commercial Services, LLC [Member]
Mar. 31, 2011
Abbott Products Inc. [Member]
Feb. 28, 2011
Abbott Products Inc. [Member]
Feb. 28, 2009
Abbott Products Inc. [Member]
Mar. 31, 2011
Abbott Products Inc. [Member]
Apr. 30, 2011
Boehringer Ingelheim International GMBH [Member]
Jun. 30, 2012
Boehringer Ingelheim International GMBH [Member]
Mar. 31, 2012
Boehringer Ingelheim International GMBH [Member]
Jun. 30, 2011
Boehringer Ingelheim International GMBH [Member]
Jun. 30, 2012
Boehringer Ingelheim International GMBH [Member]
Jun. 30, 2011
Boehringer Ingelheim International GMBH [Member]
Jul. 31, 2011
Ironwood Pharmaceuticals, Inc. [Member]
Jun. 30, 2012
Ironwood Pharmaceuticals, Inc. [Member]
Mar. 31, 2012
Ironwood Pharmaceuticals, Inc. [Member]
Jun. 30, 2012
Ironwood Pharmaceuticals, Inc. [Member]
Royalty receivable percentage, 2011               26.50%                                  
Royalty receivable percentage, 2012               29.50%                                  
Royalty receivable percentage, 2013 and 2014               32.00%                                  
Royalty receivable percentage, 2015 and thereafter               34.50%                                  
Royalties $ 9,577,000 $ 67,000 $ 18,998,000 $ 232,000   $ 9,400,000   $ 18,600,000                                  
Promotional fee paid, percentage of gross margin                 75.00%                                
Promotion fee expense   11,055,000   21,317,000     11,100,000   21,300,000                                
License and other revenue 1,332,000 4,998,000 6,637,000 72,623,000   1,000,000 200,000 2,000,000 500,000                   3,900,000   4,900,000   200,000   500,000
Gain on settlement agreement       40,000,000               40,000,000                          
Upfront agreement fee received         12,000,000                 25,000,000   10,000,000           900,000      
Upfront agreement fee deferred revenue balance               5,800,000             11,300,000                    
Collaborative agreement expense incurred                   7,600,000 14,400,000                            
Milestone revenue received                         48,000,000         2,500,000           1,000,000  
Upfront agreement fee tax withholdings                               1,500,000                  
Upfront agreement fee net of tax                               8,500,000                  
Monthly management fee fulltime reps                     1,800,000                            
Monthly management fee for part-time sales reps                     500,000                            
Additional service agreement revenue                                 $ 0   $ 500,000 $ 100,000 $ 600,000       $ 100,000
Number of full-time sales representatives                     164                            
Number of part-time sales representatives                     78                            
Percent of out-of-pocket costs reimbursed to company               70.00%                                  
Percent of out-of-pocket costs reimbursed by company               30.00%